Clinical significance of prognostic and predictive markers in colorectal cancer

[1] Fearon E.R., Vogelstein B., A genetic model for colorectal tumorigenesis, Cell, 61, pp. 759-767, (1990)

[2] Johnston P.G., Allegra C.J., Colorectal cancer biology: Clinical implications, Semin. Oncol, 22, pp. 418-432, (1995)

[3] Lane D.P., Cancer p53, guardian of the genome, Nature, 358, pp. 15-16, (1992)

[4] Sjogren S., Inganas M., Norberg T., Lindgren A., Nordgren H., Holmberg L., Et al., The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry, J. Natl. Cancer Inst, 88, pp. 173-182, (1996)

[5] Kaklamanis L., Savage A., Whitehouse R., Doussis-Anagnostopoulou I., Biddolph S., Tsiotos P., Et al., Bcl-2 protein expression: Association with p53 and prognosis in colorectal cancer, Br. J. Cancer, 77, pp. 1864-1869, (1998)

[6] Bosari S., Viale G., Bossi P., Maggioni M., Coggi G., Murray J.J., Et al., Cytoplasmic accumulation of p53 protein: An independent prognostic indicator in colorectal adenocarcinomas, J. Natl. Cancer Inst, 86, pp. 681-687, (1994)

[7] Soong R., Grieu F., Robbins P., Dix B., Chen D., Parsons R., Et al., p53 alterations are associated with improved prognosis in distal colonic carcinomas, Clin. Cancer Res, 3, pp. 1405-1411, (1997)

[8] Watanabe T., Wu T.T., Catalano P.J., Ueki T., Satriano R., Haller D.G., Et al., Molecular predictors of survival after adjuvant chemotherapy for colon cancer, N. Engl. J. Med, 344, pp. 1196-1206, (2001)

[9] Allegra C.J., Parr A.L., Wold L.E., Mahoney M.R., Sargent D.J., Johnston P.G., Et al., Investigation of the prognostic and predictive value of thymidylate synthase, p53 and Ki-67 in patients with locally advanced colon cancer, J. Clin. Oncol, 20, pp. 1735-1743, (2002)

[10] Kressner U., Inganas M., Byding S., Blikstad I., Pahlman L., Glimelius B., Et al., Prognostic value of p53 genetic changes in colorectal cancer, J. Clin. Oncol, 17, pp. 593-599, (1999)

[1] Fearon E.R., Vogelstein B., A genetic model for colorectal tumorigenesis, Cell, 61, pp. 759-767, (1990)

[2] Johnston P.G., Allegra C.J., Colorectal cancer biology: Clinical implications, Semin. Oncol, 22, pp. 418-432, (1995)

[3] Lane D.P., Cancer p53, guardian of the genome, Nature, 358, pp. 15-16, (1992)

[4] Sjogren S., Inganas M., Norberg T., Lindgren A., Nordgren H., Holmberg L., Et al., The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry, J. Natl. Cancer Inst, 88, pp. 173-182, (1996)

[5] Kaklamanis L., Savage A., Whitehouse R., Doussis-Anagnostopoulou I., Biddolph S., Tsiotos P., Et al., Bcl-2 protein expression: Association with p53 and prognosis in colorectal cancer, Br. J. Cancer, 77, pp. 1864-1869, (1998)

[6] Bosari S., Viale G., Bossi P., Maggioni M., Coggi G., Murray J.J., Et al., Cytoplasmic accumulation of p53 protein: An independent prognostic indicator in colorectal adenocarcinomas, J. Natl. Cancer Inst, 86, pp. 681-687, (1994)

[7] Soong R., Grieu F., Robbins P., Dix B., Chen D., Parsons R., Et al., p53 alterations are associated with improved prognosis in distal colonic carcinomas, Clin. Cancer Res, 3, pp. 1405-1411, (1997)

[8] Watanabe T., Wu T.T., Catalano P.J., Ueki T., Satriano R., Haller D.G., Et al., Molecular predictors of survival after adjuvant chemotherapy for colon cancer, N. Engl. J. Med, 344, pp. 1196-1206, (2001)

[9] Allegra C.J., Parr A.L., Wold L.E., Mahoney M.R., Sargent D.J., Johnston P.G., Et al., Investigation of the prognostic and predictive value of thymidylate synthase, p53 and Ki-67 in patients with locally advanced colon cancer, J. Clin. Oncol, 20, pp. 1735-1743, (2002)

[10] Kressner U., Inganas M., Byding S., Blikstad I., Pahlman L., Glimelius B., Et al., Prognostic value of p53 genetic changes in colorectal cancer, J. Clin. Oncol, 17, pp. 593-599, (1999)